{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T13:31:17Z","timestamp":1793799077407,"version":"4.6.1"},"reference-count":159,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017958","name":"Health Commission of Hubei Province","doi-asserted-by":"publisher","award":["WJ2025M107"],"award-info":[{"award-number":["WJ2025M107"]}],"id":[{"id":"10.13039\/100017958","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Hubei Province Natural Science Foundation","doi-asserted-by":"publisher","award":["2026AFD029"],"award-info":[{"award-number":["2026AFD029"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["320.6750.2025-21-13"],"award-info":[{"award-number":["320.6750.2025-21-13"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["320.6750.2024-21-5"],"award-info":[{"award-number":["320.6750.2024-21-5"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["FHHA.25.3-RB-26-K-34"],"award-info":[{"award-number":["FHHA.25.3-RB-26-K-34"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.intimp.2026.117456","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:31:15Z","timestamp":1790069475000},"page":"117456","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Fibrotic mechanobiological microenvironments drive mechano-immune exclusion and immunotherapy resistance in breast cancer: mechanisms, stratification and therapeutic opportunities"],"prefix":"10.1016","volume":"189","author":[{"given":"Senyang","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2026.117456_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.intimp.2026.117456_bb0010","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1158\/1078-0432.CCR-16-3001","article-title":"Breast Cancer immunotherapy: facts and hopes","volume":"24","author":"Emens","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2026.117456_bb0015","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S1470-2045(17)30904-X","article-title":"Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy","volume":"19","author":"Denkert","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.intimp.2026.117456_bb0020","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.annonc.2024.02.002","article-title":"Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC: exploratory analysis from KEYNOTE-522","volume":"35","author":"Pusztai","year":"2024","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.intimp.2026.117456_bb0025","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa2202809","article-title":"Pembrolizumab plus chemotherapy in advanced triple-negative breast Cancer","volume":"387","author":"Cortes","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2026.117456_bb0030","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.intimp.2026.117456_bb0035","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.immuni.2019.12.011","article-title":"Top 10 challenges in Cancer immunotherapy","volume":"52","author":"Hegde","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2026.117456_bb0040","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrc.2016.36","article-title":"Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy","volume":"16","author":"Topalian","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.intimp.2026.117456_bb0045","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of Cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.intimp.2026.117456_bb0050","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2026.117456_bb0055","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2026.117456_bb0060","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1126\/science.aaa6204","article-title":"T cell exclusion, immune privilege, and the tumor microenvironment","volume":"348","author":"Joyce","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.intimp.2026.117456_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology meets immunology: the cancer-immunity cycle","volume":"39","author":"Chen","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2026.117456_bb0070","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer-immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2026.117456_bb0075","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1126\/science.aaa8172","article-title":"The future of immune checkpoint therapy","volume":"348","author":"Sharma","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.intimp.2026.117456_bb0080","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","article-title":"Approaches to treat immune hot, altered and cold tumours with combination immunotherapies","volume":"18","author":"Galon","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.intimp.2026.117456_bb0085","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2026.117456_bb0090","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.immuni.2019.12.018","article-title":"Tumor immunology and tumor evolution: intertwined histories","volume":"52","author":"Galon","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2026.117456_bb0095","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1172\/JCI45817","article-title":"Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors","volume":"122","author":"Salmon","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2026.117456_bb0100","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41577-022-00761-w","article-title":"Tuning immunity through tissue mechanotransduction","volume":"23","author":"Du","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2026.117456_bb0105","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13045-025-01717-y","article-title":"Extracellular matrix dynamics in tumor immunoregulation: from tumor microenvironment to immunotherapy","volume":"18","author":"Hu","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.intimp.2026.117456_bb0110","doi-asserted-by":"crossref","first-page":"eadg3840","DOI":"10.1126\/scitranslmed.adg3840","article-title":"The extracellular matrix as hallmark of cancer and metastasis: from biomechanics to therapeutic targets","volume":"16","author":"Sleeboom","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.intimp.2026.117456_bb0115","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrc2544","article-title":"A tense situation: forcing tumour progression","volume":"9","author":"Butcher","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.intimp.2026.117456_bb0120","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.15252\/embr.201439246","article-title":"The extracellular matrix modulates the hallmarks of cancer","volume":"15","author":"Pickup","year":"2014","journal-title":"EMBO Rep."},{"key":"10.1016\/j.intimp.2026.117456_bb0125","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.tcb.2016.03.007","article-title":"Force matters: biomechanical regulation of cell invasion and migration in disease","volume":"26","author":"Kai","year":"2016","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.intimp.2026.117456_bb0130","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.devcel.2010.05.012","article-title":"Tumors as organs: complex tissues that interface with the entire organism","volume":"18","author":"Egeblad","year":"2010","journal-title":"Dev. Cell"},{"key":"10.1016\/j.intimp.2026.117456_bb0135","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.cell.2009.10.027","article-title":"Matrix crosslinking forces tumor progression by enhancing integrin signaling","volume":"139","author":"Levental","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2026.117456_bb0140","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nrm3904","article-title":"Remodelling the extracellular matrix in development and disease","volume":"15","author":"Bonnans","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.intimp.2026.117456_bb0145","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41568-020-00329-7","article-title":"The matrix in cancer","volume":"21","author":"Cox","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.intimp.2026.117456_bb0150","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1038\/s41467-020-18794-x","article-title":"Concepts of extracellular matrix remodelling in tumour progression and metastasis","volume":"11","author":"Winkler","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.117456_bb0155","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrc3319","article-title":"The rationale for targeting the LOX family in cancer","volume":"12","author":"Barker","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.intimp.2026.117456_bb0160","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1083\/jcb.201102147","article-title":"The extracellular matrix: a dynamic niche in cancer progression","volume":"196","author":"Lu","year":"2012","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.intimp.2026.117456_bb0165","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc.2016.73","article-title":"The biology and function of fibroblasts in cancer","volume":"16","author":"Kalluri","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.intimp.2026.117456_bb0170","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaz0868","article-title":"Physical traits of cancer","volume":"370","author":"Nia","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.intimp.2026.117456_bb0175","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1126\/science.1116995","article-title":"Tissue cells feel and respond to the stiffness of their substrate","volume":"310","author":"Discher","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.intimp.2026.117456_bb0180","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.cell.2006.06.044","article-title":"Matrix elasticity directs stem cell lineage specification","volume":"126","author":"Engler","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2026.117456_bb0185","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrm2593","article-title":"Environmental sensing through focal adhesions","volume":"10","author":"Geiger","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.intimp.2026.117456_bb0190","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/nrm3896","article-title":"Mechanotransduction and extracellular matrix homeostasis","volume":"15","author":"Humphrey","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.intimp.2026.117456_bb0195","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nrc3080","article-title":"The physics of cancer: the role of physical interactions and mechanical forces in metastasis","volume":"11","author":"Wirtz","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.intimp.2026.117456_bb0200","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fcell.2018.00017","article-title":"Feeling stress: the mechanics of Cancer progression and aggression","volume":"6","author":"Northcott","year":"2018","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.intimp.2026.117456_bb0205","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nm.3497","article-title":"Tissue mechanics modulate microRNA-dependent PTEN expression to regulate malignant progression","volume":"20","author":"Mouw","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2026.117456_bb0210","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/ncb3157","article-title":"Matrix stiffness drives epithelial-mesenchymal transition and tumour metastasis through a TWIST1-G3BP2 mechanotransduction pathway","volume":"17","author":"Wei","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.intimp.2026.117456_bb0215","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.cell.2017.10.008","article-title":"Force triggers YAP nuclear entry by regulating transport across nuclear pores","volume":"171","author":"Elosegui-Artola","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2026.117456_bb0220","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature10137","article-title":"Role of YAP\/TAZ in mechanotransduction","volume":"474","author":"Dupont","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2026.117456_bb0225","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.ccell.2016.05.005","article-title":"YAP\/TAZ at the roots of Cancer","volume":"29","author":"Zanconato","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2026.117456_bb0230","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nrm.2017.87","article-title":"Mechanobiology of YAP and TAZ in physiology and disease","volume":"18","author":"Panciera","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.intimp.2026.117456_bb0235","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.ccr.2011.05.008","article-title":"Actomyosin-mediated cellular tension drives increased tissue stiffness and \u03b2-catenin activation to induce epidermal hyperplasia and tumor growth","volume":"19","author":"Samuel","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2026.117456_bb0240","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nm.4082","article-title":"Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression","volume":"22","author":"Laklai","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2026.117456_bb0245","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/ncb2756","article-title":"Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts","volume":"15","author":"Calvo","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.intimp.2026.117456_bb0250","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ccr.2005.08.010","article-title":"Tensional homeostasis and the malignant phenotype","volume":"8","author":"Paszek","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2026.117456_bb0255","article-title":"Inhibiting NEDD4 in triple-negative breast cancer cells reprograms tumor immune microenvironment via the \u03b2-TrCP\/YAP\/ECM axis","volume":"6","author":"Su","year":"2025","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.intimp.2026.117456_bb0260","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.matbio.2023.05.006","article-title":"Matrix stiffening facilitates the collective invasion of breast cancer through the periostin-integrin mechanotransduction pathway","volume":"121","author":"Wu","year":"2023","journal-title":"Matrix Biol."},{"key":"10.1016\/j.intimp.2026.117456_bb0265","doi-asserted-by":"crossref","DOI":"10.1186\/1741-7015-6-11","article-title":"Collagen density promotes mammary tumor initiation and progression","volume":"6","author":"Provenzano","year":"2008","journal-title":"BMC Med."},{"key":"10.1016\/j.intimp.2026.117456_bb0270","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1741-7015-4-38","article-title":"Collagen reorganization at the tumor-stromal interface facilitates local invasion","volume":"4","author":"Provenzano","year":"2006","journal-title":"BMC Med."},{"key":"10.1016\/j.intimp.2026.117456_bb0275","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.ajpath.2010.11.076","article-title":"Aligned collagen is a prognostic signature for survival in human breast carcinoma","volume":"178","author":"Conklin","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.intimp.2026.117456_bb0280","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","article-title":"A single-cell and spatially resolved atlas of human breast cancers","volume":"53","author":"Wu","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.intimp.2026.117456_bb0285","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1039\/c5ib00040h","article-title":"Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration","volume":"7","author":"Acerbi","year":"2015","journal-title":"Integr Biol (Camb)"},{"key":"10.1016\/j.intimp.2026.117456_bb0290","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41586-019-1876-x","article-title":"The single-cell pathology landscape of breast cancer","volume":"578","author":"Jackson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2026.117456_bb0295","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1038\/s41467-023-39085-1","article-title":"A convolutional neural network STIFMap reveals associations between stromal stiffness and EMT in breast cancer","volume":"14","author":"Stashko","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.117456_bb0300","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s40425-019-0556-6","article-title":"Collagen density regulates the activity of tumor-infiltrating T cells","volume":"7","author":"Kuczek","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.intimp.2026.117456_bb0305","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-18298-8","article-title":"Collagen promotes anti-PD-1\/PD-L1 resistance in cancer through LAIR1-dependent CD8(+) T cell exhaustion","volume":"11","author":"Peng","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.117456_bb0310","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1158\/2767-9764.CRC-25-0259","article-title":"Collagen-bearing exosomes from breast Cancer-associated fibroblasts promote T-cell dysfunction","volume":"6","author":"Jana","year":"2026","journal-title":"Cancer Res Commun"},{"key":"10.1016\/j.intimp.2026.117456_bb0315","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","article-title":"A framework for advancing our understanding of cancer-associated fibroblasts","volume":"20","author":"Sahai","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.intimp.2026.117456_bb0320","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ccell.2018.01.011","article-title":"Fibroblast heterogeneity and immunosuppressive environment in human breast cancer","volume":"33","author":"Costa","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2026.117456_bb0325","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.1038\/s41467-018-07582-3","article-title":"Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing","volume":"9","author":"Bartoschek","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.117456_bb0330","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41467-019-14134-w","article-title":"Cancer-associated fibroblast heterogeneity in axillary lymph nodes drives metastases in breast cancer through complementary mechanisms","volume":"11","author":"Pelon","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.117456_bb0335","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.57243","article-title":"Cancer-associated fibroblasts and their influence on tumor immunity and immunotherapy","volume":"9","author":"Barrett","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.intimp.2026.117456_bb0340","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/s41571-021-00546-5","article-title":"Clinical and therapeutic relevance of cancer-associated fibroblasts","volume":"18","author":"Chen","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.intimp.2026.117456_bb0345","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/s41563-020-00849-5","article-title":"Tumour-associated macrophages drive stromal cell-dependent collagen crosslinking and stiffening to promote breast cancer aggression","volume":"20","author":"Maller","year":"2021","journal-title":"Nat. Mater."},{"key":"10.1016\/j.intimp.2026.117456_bb0350","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1002\/ijc.70018","article-title":"The role of SPP1(+)TAMs in cancer: impact on patient prognosis and future therapeutic targets","volume":"157","author":"Li","year":"2025","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.intimp.2026.117456_bb0355","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/path.6395","article-title":"Extracellular matrix cancer-associated fibroblasts promote stromal fibrosis and immune exclusion in triple-negative breast cancer","volume":"265","author":"Lu","year":"2025","journal-title":"J. Pathol."},{"key":"10.1016\/j.intimp.2026.117456_bb0360","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009877","article-title":"AKAP12 positive fibroblast determines immunosuppressive contexture and immunotherapy response in patients with TNBC by promoting macrophage M2 polarization","volume":"12","author":"Liu","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.intimp.2026.117456_bb0365","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/s43018-024-00775-4","article-title":"Tumor-associated macrophages restrict CD8(+) T cell function through collagen deposition and metabolic reprogramming of the breast cancer microenvironment","volume":"5","author":"Tharp","year":"2024","journal-title":"Nat Cancer"},{"key":"10.1016\/j.intimp.2026.117456_bb0370","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1158\/0008-5472.CAN-22-1427","article-title":"Lipid-associated macrophages are induced by Cancer-associated fibroblasts and mediate immune suppression in breast Cancer","volume":"82","author":"Timperi","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2026.117456_bb0375","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1158\/0008-5472.CAN-21-4141","article-title":"Cancer-associated fibroblasts suppress CD8+ T-cell infiltration and confer resistance to immune-checkpoint blockade","volume":"82","author":"Jenkins","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2026.117456_bb0380","article-title":"Modulation of fibronectin extracellular matrix enhances anti-tumor efficacy of immune checkpoint blockade","volume":"6","author":"Khan","year":"2025","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.intimp.2026.117456_bb0385","doi-asserted-by":"crossref","first-page":"8171","DOI":"10.1038\/s41467-025-63659-w","article-title":"AEBP1 drives fibroblast-mediated T cell dysfunction in tumors","volume":"16","author":"Wang","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.117456_bb0390","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/ijc.35471","article-title":"Inhibition of autotaxin activity with IOA-289 decreases fibrosis in mouse E0771 breast tumors","volume":"157","author":"Tang","year":"2025","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.intimp.2026.117456_bb0395","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.cell.2026.01.001","article-title":"Sensory neurons drive immune exclusion by stimulating a dense extracellular matrix in the breast cancer tumor microenvironment","volume":"189","author":"Zhang","year":"2026","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2026.117456_bb0400","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-20893-2","article-title":"CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapy","volume":"12","author":"Rodriguez-Garcia","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.117456_bb0405","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nature25501","article-title":"TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2026.117456_bb0410","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/nature25492","article-title":"TGF\u03b2 drives immune evasion in genetically reconstituted colon cancer metastasis","volume":"554","author":"Tauriello","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2026.117456_bb0415","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ccr.2005.10.012","article-title":"TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance","volume":"8","author":"Thomas","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2026.117456_bb0420","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aad1884","article-title":"TGF-\u03b2 inhibits the activation and functions of NK cells by repressing the mTOR pathway","volume":"9","author":"Viel","year":"2016","journal-title":"Sci. Signal."},{"key":"10.1016\/j.intimp.2026.117456_bb0425","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1158\/0008-5472.CAN-12-4521","article-title":"Coevolution of solid stress and interstitial fluid pressure in tumors during progression: implications for vascular collapse","volume":"73","author":"Stylianopoulos","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2026.117456_bb0430","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev-bioeng-071813-105259","article-title":"The role of mechanical forces in tumor growth and therapy","volume":"16","author":"Jain","year":"2014","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.intimp.2026.117456_bb0435","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1200\/JCO.2012.46.3653","article-title":"Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers","volume":"31","author":"Jain","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.intimp.2026.117456_bb0440","doi-asserted-by":"crossref","first-page":"15101","DOI":"10.1073\/pnas.1213353109","article-title":"Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors","volume":"109","author":"Stylianopoulos","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2026.117456_bb0445","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nm.3541","article-title":"Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors","volume":"20","author":"Motz","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2026.117456_bb0450","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.actbio.2023.06.007","article-title":"Ultrasound stiffness and perfusion markers correlate with tumor volume responses to immunotherapy","volume":"167","author":"Voutouri","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.intimp.2026.117456_bb0455","doi-asserted-by":"crossref","first-page":"5420","DOI":"10.1097\/JS9.0000000000002636","article-title":"Mechanical forces and immune cells in the tumor microenvironment: from regulation mechanisms to therapeutic strategies","volume":"111","author":"Ren","year":"2025","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.intimp.2026.117456_bb0460","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200053","article-title":"Mechanosensing through YAP controls T cell activation and metabolism","volume":"217","author":"Meng","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2026.117456_bb0465","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.4049\/jimmunol.1102757","article-title":"Substrate rigidity regulates human T cell activation and proliferation","volume":"189","author":"O\u2019Connor","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2026.117456_bb0470","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1016\/j.cell.2024.04.023","article-title":"Osr2 functions as a biomechanical checkpoint to aggravate CD8(+) T cell exhaustion in tumor","volume":"187","author":"Zhang","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2026.117456_bb0475","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/s41551-024-01188-5","article-title":"PIEZO1 mechanically regulates the antitumour cytotoxicity of T lymphocytes","volume":"8","author":"Pang","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.intimp.2026.117456_bb0480","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202350693","article-title":"PIEZO1-mediated mechanosensing governs NK-cell killing efficiency and infiltration in three-dimensional matrices","volume":"54","author":"Yanamandra","year":"2024","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.intimp.2026.117456_bb0485","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1038\/s41467-021-23482-5","article-title":"Mechanically activated ion channel Piezo1 modulates macrophage polarization and stiffness sensing","volume":"12","author":"Atcha","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.117456_bb0490","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1073\/pnas.1315606111","article-title":"CD28 and CD3 have complementary roles in T-cell traction forces","volume":"111","author":"Bashour","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2026.117456_bb0495","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.23190","article-title":"Different TCR-induced T lymphocyte responses are potentiated by stiffness with variable sensitivity","volume":"6","author":"Saitakis","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.intimp.2026.117456_bb0500","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.4049\/jimmunol.1701118","article-title":"Cutting edge: Piezo1 Mechanosensors optimize human T cell activation","volume":"200","author":"Liu","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2026.117456_bb0505","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41586-019-1485-8","article-title":"Mechanosensation of cyclical force by PIEZO1 is essential for innate immunity","volume":"573","author":"Solis","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2026.117456_bb0510","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41586-021-04057-2","article-title":"Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion","volume":"599","author":"Sun","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2026.117456_bb0515","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.58688","article-title":"Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment","volume":"10","author":"Nicolas-Boluda","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.intimp.2026.117456_bb0520","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1038\/s41388-018-0320-2","article-title":"LOX-catalyzed collagen stabilization is a proximal cause for intrinsic resistance to chemotherapy","volume":"37","author":"Rossow","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.intimp.2026.117456_bb0525","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1038\/s43018-023-00614-y","article-title":"A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer","volume":"4","author":"Chitty","year":"2023","journal-title":"Nat Cancer"},{"key":"10.1016\/j.intimp.2026.117456_bb0530","article-title":"Targeting the MAtrix REgulating MOtif abolishes several hallmarks of cancer, triggering antitumor immunity","volume":"121","author":"Li","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2026.117456_bb0535","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12237","article-title":"Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription","volume":"7","author":"Kaukonen","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.117456_bb0540","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jconrel.2016.09.004","article-title":"Tumor stroma-containing 3D spheroid arrays: a tool to study nanoparticle penetration","volume":"244","author":"Priwitaningrum","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.intimp.2026.117456_bb0545","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nm.4123","article-title":"Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy","volume":"22","author":"Jiang","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2026.117456_bb0550","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ccr.2014.04.021","article-title":"Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma","volume":"25","author":"Rhim","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2026.117456_bb0555","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ccr.2014.04.005","article-title":"Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival","volume":"25","author":"\u00d6zdemir","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2026.117456_bb0560","doi-asserted-by":"crossref","first-page":"20212","DOI":"10.1073\/pnas.1320318110","article-title":"Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer","volume":"110","author":"Feig","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2026.117456_bb0565","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1126\/science.1195300","article-title":"Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha","volume":"330","author":"Kraman","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.intimp.2026.117456_bb0570","doi-asserted-by":"crossref","first-page":"6852","DOI":"10.1158\/0008-5472.CAN-18-1750","article-title":"An oncolytic virus expressing a T-cell engager simultaneously targets Cancer and immunosuppressive stromal cells","volume":"78","author":"Freedman","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2026.117456_bb0575","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1084\/jem.20180818","article-title":"Bone marrow-derived fibroblasts are a functionally distinct stromal cell population in breast cancer","volume":"215","author":"Raz","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2026.117456_bb0580","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1151373","article-title":"The origins, roles and therapies of cancer associated fibroblast in liver cancer","volume":"13","author":"Zulaziz","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.intimp.2026.117456_bb0585","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","article-title":"Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives","volume":"20","author":"Mao","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.intimp.2026.117456_bb0590","article-title":"Dendritic polymer-based nanomedicines remodel the tumor stroma: improve drug penetration and enhance antitumor immune response","volume":"36","author":"Zhang","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.intimp.2026.117456_bb0595","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113606","article-title":"Stimuli-responsive polymer-dasatinib prodrug to reprogram cancer-associated fibroblasts for boosted immunotherapy","volume":"381","author":"Zhang","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.intimp.2026.117456_bb0600","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.actbio.2025.03.001","article-title":"Overcoming matrix barriers for enhanced immune infiltration using siRNA-coated metal-organic frameworks","volume":"196","author":"Zeng","year":"2025","journal-title":"Acta Biomater."},{"key":"10.1016\/j.intimp.2026.117456_bb0605","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202500176","article-title":"Cascade-responsive nanoprodrug disrupts immune-fibroblast communications for potentiated cancer mechanoimmunotherapy","volume":"14","author":"Guan","year":"2025","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.intimp.2026.117456_bb0610","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1056\/NEJMoa2409932","article-title":"Overall survival with Pembrolizumab in early-stage triple-negative breast Cancer","volume":"391","author":"Schmid","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2026.117456_bb0615","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJMoa2112651","article-title":"Event-free survival with Pembrolizumab in early triple-negative breast Cancer","volume":"386","author":"Schmid","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2026.117456_bb0620","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa1910549","article-title":"Pembrolizumab for early triple-negative breast Cancer","volume":"382","author":"Schmid","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2026.117456_bb0625","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1056\/NEJMoa1809615","article-title":"Atezolizumab and nab-paclitaxel in advanced triple-negative breast Cancer","volume":"379","author":"Schmid","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2026.117456_bb0630","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.annonc.2021.05.355","article-title":"First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis","volume":"32","author":"Emens","year":"2021","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.intimp.2026.117456_bb0635","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.annonc.2021.05.801","article-title":"Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced\/metastatic triple-negative breast cancer","volume":"32","author":"Miles","year":"2021","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.intimp.2026.117456_bb0640","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0140-6736(20)31953-X","article-title":"Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial","volume":"396","author":"Mittendorf","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2026.117456_bb0645","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/annonc\/mdz158","article-title":"A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study","volume":"30","author":"Loibl","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.intimp.2026.117456_bb0650","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/annonc\/mdu450","article-title":"The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an international TILs working group 2014","volume":"26","author":"Salgado","year":"2015","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.intimp.2026.117456_bb0655","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ccr.2012.01.007","article-title":"Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma","volume":"21","author":"Provenzano","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2026.117456_bb0660","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrc1877","article-title":"Fibroblasts in cancer","volume":"6","author":"Kalluri","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.intimp.2026.117456_bb0665","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.semcancer.2013.12.008","article-title":"TGF-beta in CAF-mediated tumor growth and metastasis","volume":"25","author":"Calon","year":"2014","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.intimp.2026.117456_bb0670","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1084\/jem.20162024","article-title":"Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer","volume":"214","author":"\u00d6hlund","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2026.117456_bb0675","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ccr.2008.11.012","article-title":"Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche","volume":"15","author":"Erler","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2026.117456_bb0680","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1158\/0008-5472.CAN-12-2233","article-title":"LOX-mediated collagen crosslinking is responsible for fibrosis-enhanced metastasis","volume":"73","author":"Cox","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2026.117456_bb0685","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00248","article-title":"Metabolic hallmarks of tumor and immune cells in the tumor microenvironment","volume":"8","author":"Renner","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.117456_bb0690","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","article-title":"LDHA-associated lactic acid production blunts tumor Immunosurveillance by T and NK cells","volume":"24","author":"Brand","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.intimp.2026.117456_bb0695","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature13490","article-title":"Functional polarization of tumour-associated macrophages by tumour-derived lactic acid","volume":"513","author":"Colegio","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2026.117456_bb0700","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nrc3726","article-title":"Hypoxia and the extracellular matrix: drivers of tumour metastasis","volume":"14","author":"Gilkes","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.intimp.2026.117456_bb0705","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/ni.f.212","article-title":"Interstitial leukocyte migration and immune function","volume":"9","author":"Friedl","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2026.117456_bb0710","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1199513","article-title":"Regulation of tumor immunity and immunotherapy by the tumor collagen extracellular matrix","volume":"14","author":"Flies","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.117456_bb0715","doi-asserted-by":"crossref","first-page":"L5","DOI":"10.1016\/j.bpj.2011.12.011","article-title":"Mechanosensing in T lymphocyte activation","volume":"102","author":"Judokusumo","year":"2012","journal-title":"Biophys. J."},{"key":"10.1016\/j.intimp.2026.117456_bb0720","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12929-019-0568-z","article-title":"Tumor-associated macrophages: an accomplice in solid tumor progression","volume":"26","author":"Chen","year":"2019","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.intimp.2026.117456_bb0725","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1158\/2159-8290.CD-18-0710","article-title":"IL1-induced JAK\/STAT signaling is antagonized by TGF\u03b2 to shape CAF heterogeneity in pancreatic ductal adenocarcinoma","volume":"9","author":"Biffi","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.intimp.2026.117456_bb0730","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14133178","article-title":"Implications for immunotherapy of breast Cancer by understanding the microenvironment of a solid tumor","volume":"14","author":"Franz\u00e9n","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.intimp.2026.117456_bb0735","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.cmet.2022.11.013","article-title":"Microenvironmental ammonia enhances T cell exhaustion in colorectal cancer","volume":"35","author":"Bell","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.intimp.2026.117456_bb0740","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.ccell.2021.04.014","article-title":"Conserved pan-cancer microenvironment subtypes predict response to immunotherapy","volume":"39","author":"Bagaev","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2026.117456_bb0745","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1038\/s41590-025-02321-5","article-title":"Thrombospondin-1-CD47 signaling contributes to the development of T cell exhaustion in cancer","volume":"26","author":"Weng","year":"2025","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2026.117456_bb0750","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1038\/s41416-021-01353-6","article-title":"Promises and challenges of adoptive T-cell therapies for solid tumours","volume":"124","author":"Morotti","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.intimp.2026.117456_bb0755","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1158\/2159-8290.CD-24-0131","article-title":"Cancer-associated fibroblasts serve as decoys to suppress NK cell anticancer cytotoxicity in breast Cancer","volume":"15","author":"Ben-Shmuel","year":"2025","journal-title":"Cancer Discov."},{"key":"10.1016\/j.intimp.2026.117456_bb0760","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1158\/2159-8290.CD-19-0644","article-title":"Single-cell RNA sequencing reveals stromal evolution into LRRC15(+) Myofibroblasts as a determinant of patient response to Cancer immunotherapy","volume":"10","author":"Dominguez","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.intimp.2026.117456_bb0765","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41586-022-05272-1","article-title":"LRRC15(+) myofibroblasts dictate the stromal setpoint to suppress tumour immunity","volume":"611","author":"Krishnamurty","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2026.117456_bb0770","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.ccell.2024.08.020","article-title":"Cross-tissue human fibroblast atlas reveals myofibroblast subtypes with distinct roles in immune modulation","volume":"42","author":"Gao","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2026.117456_bb0775","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1038\/s41467-024-46504-4","article-title":"Metabolic targeting of cancer associated fibroblasts overcomes T-cell exclusion and chemoresistance in soft-tissue sarcomas","volume":"15","author":"Broz","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.117456_bb0780","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/bjc.2013.768","article-title":"Cancer-associated fibroblasts induce epithelial-mesenchymal transition of breast cancer cells through paracrine TGF-\u03b2 signalling","volume":"110","author":"Yu","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.intimp.2026.117456_bb0785","doi-asserted-by":"crossref","first-page":"6162","DOI":"10.1038\/s41467-024-50441-7","article-title":"Senescent cancer-associated fibroblasts in pancreatic adenocarcinoma restrict CD8(+) T cell activation and limit responsiveness to immunotherapy in mice","volume":"15","author":"Assouline","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.117456_bb0790","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/path.4114","article-title":"Physical and chemical microenvironmental cues orthogonally control the degree and duration of fibrosis-associated epithelial-to-mesenchymal transitions","volume":"229","author":"Brown","year":"2013","journal-title":"J. Pathol."},{"key":"10.1016\/j.intimp.2026.117456_bb0795","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-025-03518-0","article-title":"ECM-induced IL-23 drives immune suppression in breast cancer via regulating PD-1 on Tregs","volume":"44","author":"Talarico","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926013032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926013032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T12:48:40Z","timestamp":1793796520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926013032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":159,"alternative-id":["S1567576926013032"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117456","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibrotic mechanobiological microenvironments drive mechano-immune exclusion and immunotherapy resistance in breast cancer: mechanisms, stratification and therapeutic opportunities","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117456","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117456"}}